BU Now » AVR http://blogs.bu.edu/bunow News, information and research from Boston University Wed, 21 Sep 2011 18:14:24 +0000 en hourly 1 http://wordpress.org/?v=3.1.4 GlaxoSmithKline and Pfizer combine HIV-drug business http://blogs.bu.edu/bunow/2009/04/16/glaxosmithkline-and-pfizer-combine-hiv-drug-business/ http://blogs.bu.edu/bunow/2009/04/16/glaxosmithkline-and-pfizer-combine-hiv-drug-business/#comments Thu, 16 Apr 2009 19:59:31 +0000 Dick Taffe http://blogs.bu.edu/bunow/?p=278

Law Professor Kevin Outterson, director of the Health Law Program, says big pharma giants GlaxoSmithKline and Pfizer combining their HIV-drug business should be good for the companies and for patients around the globe.

“The joint venture will allow GSK and Pfizer to coordinate antiretroviral-drug research, which will both lower R&D costs and reduce competition between the companies. 

“Given the global importance of this drug category, and Glaxo CEO Andrew Witty’s recent comments on global access to drugs, I hope the joint venture will issue a clear statement on affordable access to ARVs across the entire world.”

Contact Kevin Outterson, 617-353-3103, mko@bu.edu

]]> http://blogs.bu.edu/bunow/2009/04/16/glaxosmithkline-and-pfizer-combine-hiv-drug-business/feed/ 0